Free Trial

Eliem Therapeutics (ELYM) SEC Filings & 10K Form

$8.65
-0.25 (-2.81%)
(As of 07/26/2024 ET)

Recent Eliem Therapeutics SEC Filings

DateFilerForm TypeView
07/23/2024
11:15 PM
Eliem Therapeutics (Filer)
Form EFFECT
07/23/2024
4:04 PM
Eliem Therapeutics (Issuer)
Morisset Valerie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
3:31 PM
Eliem Therapeutics (Filer)
Form 424B3
07/19/2024
10:12 AM
Eliem Therapeutics (Issuer)
Morisset Valerie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
5:11 PM
Eliem Therapeutics (Issuer)
Morisset Valerie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
5:14 PM
Eliem Therapeutics (Issuer)
Morisset Valerie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
7:45 PM
Eliem Therapeutics (Issuer)
Morisset Valerie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:46 PM
Eliem Therapeutics (Issuer)
Morisset Valerie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:42 PM
Eliem Therapeutics (Issuer)
Morisset Valerie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:38 PM
Eliem Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
07/02/2024
3:39 PM
Eliem Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
07/02/2024
3:01 PM
Deep Track Capital, LP (Filed by)
Eliem Therapeutics (Subject)
Form SC 13G
07/01/2024
8:28 PM
Eliem Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
07/01/2024
8:29 PM
Eliem Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
5:09 PM
Eliem Therapeutics (Issuer)
Levin Andrew David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
5:14 PM
Eliem Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
4:23 PM
Dunn Judith (Reporting)
Eliem Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
4:26 PM
Eliem Therapeutics (Issuer)
Rosenberg Adam Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
4:09 PM
Eliem Therapeutics (Issuer)
Ratcliffe Liam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
4:13 PM
Eliem Therapeutics (Issuer)
Tate Simon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
6:00 PM
Brennan Aoife (Reporting)
Eliem Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/27/2024
6:01 PM
Eliem Therapeutics (Issuer)
Thomas Stephen Basil (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/27/2024
6:03 PM
Eliem Therapeutics (Issuer)
Thomas Stephen Basil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
6:05 PM
Brennan Aoife (Reporting)
Eliem Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:22 PM
Eliem Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2024
3:23 PM
Eliem Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
1:57 PM
Eliem Therapeutics (Issuer)
Pimblett Emily (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
3:41 PM
Eliem Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2024
3:42 PM
Eliem Therapeutics (Filer)
Form DEFA14A
06/04/2024
7:00 AM
Eliem Therapeutics (Filer)
Form DEFM14A
06/04/2024
7:05 AM
Eliem Therapeutics (Filer)
Form ARS
05/15/2024
5:19 AM
Eliem Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
5:01 PM
Affinity Asset Advisors, LLC (Filed by)
Eliem Therapeutics (Subject)
Form SC 13G
04/12/2024
5:52 PM
Eliem Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
04/11/2024
7:01 AM
Eliem Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
7:10 AM
Eliem Therapeutics (Filer)
Form DEFA14A
04/08/2024
4:33 PM
Eliem Therapeutics (Issuer)
Morisset Valerie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:05 PM
Eliem Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2024
3:33 PM
Eliem Therapeutics (Issuer)
Pimblett Emily (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
10:07 AM
Eliem Therapeutics (Issuer)
Morisset Valerie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
10:53 AM
BML Investment Partners, L.P. (Filed by)
Eliem Therapeutics (Subject)
Form SC 13G/A
Don't Pay a Dime for Marc Lichtenfeld's Top AI Picks (Ad)

Usually, you'd have to plunk down a hefty sum to get your hands on Marc Lichtenfeld's latest income research... But today, the author of Get Rich with Dividends is feeling extra generous...

Click here now to claim your FREE copy of Marc's AI playbook.
11/17/2023
3:30 PM
Eliem Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
11/14/2023
3:01 PM
Eliem Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2023
4:13 PM
AI ETI LLC (Filed by)
Eliem Therapeutics (Subject)
Form SC 13D/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ELYM) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners